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Recent studies have identified differences in cancer risk, severity, and response to treatments in 
different ethnic groups. When comparing Americans of African descent to those of Caucasian 
descent, symptoms in African American patients were consistently severe with increased 
mortality rates. Research has indicated that this difference in the cancer phenotype between these 
two ethnic groups may be a result of both biological and socioeconomic factors1. Our current 
study will focus on the potential- biological factors. We hypothesize that vitamin D deficiency in 
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the AA population and associated differences in DNA repair capacity are the biological basis of 
the cancer- phenotypic variance between these populations. 
 
Lymphoblastic (LCL) cell lines cataloged in (http://www.1000genomes.org/) with known 
genotypes of human repair genes will be quantified for DNA repair capacity using comet assay, 
cell cycle analysis, and gene expression of key DNA repair genes (for both ethnic groups) after 
exposure to DNA damaging chemotherapeutic agents. Chi-square based population association 
approach will be used to associate genotypes of DNA repair genes to DRC capacity, thus 
providing the basis of population difference in the cancer phenotype. 
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NOMENCLATURE 
 
AA     African American 
CA     Caucasian American 
DRC    DNA Repair Capacity 
PCA     Principal Component Analysis 
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CHAPTER I 
INTRODUCTION 
 
Several socioeconomic and biological factors have been shown to influence the disparity in 
cancer presentation and outcomes in AA and CA. Despite socioeconomic factors, such as late 
stage clinical presentation and decreased access to health care resources, being shown to have an 
influence on cancer outcomes, differences in the two populations persisted even after matching 
them for socioeconomic conditions. Several parameters including clinical, biological and cellular 
characteristics such as mortality, age of onset, hormonal status, S phase status, and tumor size, 
differed between the populations1-3. A strong link between DRC and cancer propensity has been 
well documented in the current literature3. Furthermore, recent research demonstrates that the 
serum concentration of vitamin D is directly related to the DRC of cells and thus propensity to 
develop cancer4,5. Vitamin D deficiency in AA population is known and has been concomitant to 
population movement from tropical zones (more direct sunlight) to temperate zones (less direct 
sunlight)6,7. The vitamin D deficiency identified in the AA population in the United States thus 
may be attributed to decreased absorption of Vitamin D that is modulated both by available 
sunlight and melanin pigments of the skin6-8. Although it is clear that there is a biological 
component in the cancer disparity between the AA and CA populations, there is no clear 
explanation as to the underlying cause behind this dissimilarity3,8. 
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Here, we address this gap in knowledge by proposing a novel, testable hypothesis. We 
hypothesize that difference in cancer severity between the two populations is due to differences 
in DNA repair capacity associated with Vitamin D deficiency. To test this hypothesis, we will 
evaluate the extent of DNA repair after exposure to commonly prescribed chemotherapy agents 
with and without Vitamin D in AA and CA population. We expect to find differences in DRC 
linked to DNA repair enzyme polymorphism frequencies in the population and vitamin D 
concentration in the serum. 
 
Vitamin D and DNA Repair 
DNA damage is a relatively common natural phenomenon in which DNA acquires a mutation or 
is broken. A normal cell will be able to undergo DNA repair in response to the damage by a 
variety of mechanisms.  Repair mechanisms mend damages, which would otherwise have 
interrupted with DNA’s principal functions of replication and transcription, and correct DNA 
mutations9. Cells that are unable to sufficiently repair DNA can begin to accumulate damage, 
which can lead to genomic instability10. Furthermore, patients with diminished DNA repair 
ability have been found to be at much higher risk for breast cancer than patients with normal 
levels of DNA repair5.  
 
Vitamin D is a known cofactor of many biological pathways, including DNA repair, so it is 
assumed that the level of vitamin D in the body may affect cancer risk and severity. Deficiencies 
in vitamin D are linked to increased frequencies of DNA breaks, both single and double 
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stranded, due to elevated levels of stress11. Some of the populational differences in cancer 
characteristics are attributed to gene variants (SNPs) that may directly affect the vitamin D 
metabolism pathways, resulting in varied serum concentration levels among different 
populations12.  Increasing the amount of serum vitamin D could promote repair of damaged 
DNA, thus helping to maintain DNA integrity and stability. This in turn would lead to a 
reduction in the levels of damaged DNA present in the cells, which could help decrease breast 
cancer risk13. 
 
Techniques 
By challenging Lymphoblastoid cell lines (LCLs) with known genotypes from both AA and CA 
through exposure to DNA damaging chemotherapeutic drugs, and measuring the amount of 
DNA repair when supplemented with vitamin D, we plan to correlate the phenotypic 
observations with genotypes using the various experimental techniques described as follows: 
 
Cell Cycle Analysis 
Cell cycle analysis is utilized to determine the amount of cell aggregates in each phase of the cell 
cycle. This is evaluated by staining cells with Propidium Iodide and analyzed using flow 
cytometry. 
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Real-Time PCR 
To determine the transcriptomics of DNA repair gene pathways, Real-time PCR is conducted by 
isolating the cellular RNA and reverse transcribing it to cDNA. Two-hundred genes in six major 
DNA repair pathways will be analyzed for gene expression, allowing us to determine gene 
alterations in DNA repair pathways. 
 
Based on the data, we intend to expand our research focus to discovering specific DNA repair 
pathways that differ between the two populations. By applying the knowledge of the clinical 
(phenotypic) differences in presentation and outcome between these populations to molecular 
underpinning behind (genotype) them, we plan to identify factors that can be exploited to 
eliminate cancer disparities. This study will prove beneficial in the cancer survival outcomes in 
both AAs and CAs.  
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CHAPTER II 
MATERIALS AND METHODS 
 
Selection of Cell Lines 
Twenty-four Lymphoblastoid cell lines (LCLs) were purchased from the Coriell Institute (NJ, 
USA) and were selected based on high fixation index (Fst), which is a measure of population 
differentiation due to genetic structure in their SNPS that discerned them from each other. To 
avoid genomic admixture issues, the cell lines were selected from two independently segregating 
populations: Caucasian (Utah (USA) Families, CEPH) and African (Nigerian families, YRI). 
Twelve cell lines were obtained from the Caucasian populations and 12 cell lines were obtained 
from the African populations. The SNPs were chosen from genes participating in DNA repair 
and Vitamin D metabolism pathways.  All of these cell lines had been obtained and anonymized 
by the National Institute of General Medical Sciences prior to deposit, and all subjects had 
provided written consent for the use of their DNA and cells for experimental purposes.  
 
Tissue Culture Methodology 
LCL cell lines were maintained in RPMI medium 1640 with 1% L-glutamine (GIBCO) 
supplemented with 10% FBS (Atlanta, Biologicals) in T-25 tissue culture flasks. Cell counts 
were made and trypan blue exclusion assays were used for cell viability estimation. At the time 
of experimentation, cell lines were >95 % viable. 
  
 
 
 
10 
 
 
 
 
Chemotherapy Drugs and Vitamin D Exposure 
Cells were seeded at a density of 2 × 105 cells/well in 24-well cluster plates (Sigma) and the 
following treatments were applied in triplicates for 12 hours: with chemotherapy drugs, with 
vitamin D, with drugs and vitamin D, and untreated controls. The cells were then transferred to 
15 mL tubes, washed with PBS, and seeded back with or without Vitamin D (Calcitriol, Tocris 
Biosciences) at 10-7 M final concentrations for another 12 hours.  The cells were then removed, 
washed with cold PBS, and fixed in 70% ethanol (v/v) overnight at 4o C. For the chemotherapy 
drugs Cyclophosmamide and Doxyrubicin, which were used in combination to mimic typical 
clinical protocols, the concentrations chosen were 800ug/ml and 80ug/ml respectively. For 
Cisplatin, the concentration used was 0.15mM. 
 
Cell Cycle Analysis  
The next day, the collected cells were centrifuged at 800 × g for 10 minutes. They were then 
washed in ice cold Phosphate Buffered Saline (PBS) twice and treated with ribonuclease (100 
ug/ml) (DNase free, Sigma ) in PBS for 30 minutes at room temperature.  Finally, the cells were 
resuspended in 50 mg/L propidium iodide (Sigma) in PBS and were immediately subjected to 
flow cytometry optimized for propidium iodide using a fluorescence-activated cell sorting 
(FACS) (BD AccuriTM C6Scan, San Jose, CA). Appropriate settings of forward and side scatter 
gates were used to examine 10,000 cells/experiment. Results were analyzed with Cell Quest 
(Becton Dickinson) and Modfit (Verity Software House, Topsham, ME) software. 
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Statistical Analysis 
Statistical analyses were performed using a standard one-way ANOVA with Dunnett's post-test 
(InStat software, GraphPad Software, San Diego, CA). Differences with P < 0.05 were 
considered significant. 
 
RNA Isolation and Characterization 
RNA was isolated from LCLs after appropriate treatments in triplicates using TRIZOL reagent 
(Invitrogen) as per the recommended protocol. Briefly, 1 ml of reagent was used per well 
followed by the addition of 200 µl chloroform. The aqueous phase was separated by 
centrifugation in a microfuge. RNA was precipitated by adding 250 µl isopropanol and isolated 
as a pellet by centrifugation. The pellet was then washed sequentially with 80% and 100% 
ethanol, and air-dried. RNA was dissolved in DEPC-treated H2O, and stored in aliquots at 
−80°C. 
 
The concentration of RNA was determined by absorbance measurements at 260 nm in a 
nanodrop spectrophotometer. The presence of contaminating proteins and organic compounds, 
such as phenol, in the RNA preparation were checked by determining absorbance ratios at 260 
nm/280 nm and 260 nm/230 nm, respectively. The quality of RNA was characterized by 
electrophoresis in 1.2% Agarose gel. The electrophoresis allowed the quantitation of 28S rRNA 
and 18S rRNA. As mammalian 28S and 18S rRNAs are approximately 5 kb and 2 kb in size, a 
2:1 ratio is considered the benchmark for intact RNA. 
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cDNA Synthesis and Gene Expression Quantification using QPCR 
10 μl RNA of 50 ng/μl was reverse-transcribed in 40-μl reactions. Reverse transcription (RT) 
was performed using the miRCURY LNA Universal RT microRNA PCR, Polyadenylation and 
cDNA synthesis kit (Exiqon). cDNA was diluted 50× and assayed in 10 μl PCR reactions 
according to the protocol for miRCURY LNA Universal RT microRNA PCR. Each miRNA was 
assayed in triplicates. The amplification was performed in a CFX Touch Real-Time PCR System 
(BIO-RAD) in 384-well plates. The amplification curves were analyzed using the CFX Manager  
TM software, both for determination of the quantification cycle (Cq; by the second derivative 
method) and for melting-curve analysis. The amplification efficiency was calculated using 
algorithms similar to the LinRegPCR software. All assays were inspected for distinct melting 
curves and the melting temperature was checked to be within known specifications for the assay. 
Furthermore, assays detected with Cq < 37 were included in the data analysis as per 
manufacturer’s instructions. Data that did not pass these criteria were omitted from any further 
analysis.  
 
The test miRNA quantification normalized data to the level of miR-425, as miR-425 levels were 
expressed close to the global mean in the screening cohort and miR-425 previously has been 
found valid as a housekeeping miRNA. 
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Statistical analysis 
The results were expressed as mean + SD. Differences between the groups were evaluated by 
analysis of variance, followed by the Tukey–Kramer test for post hoc analysis. A p-Value less 
than 0.05 was considered statistically significant. 
 
 
 
  
 
 
 
14 
 
 
 
 
Signal Pathway analysis of miRNA 
Ingenuity pathway analysis (IPA) software (Ingenuity Systems, Redwood City, CA; available 
at: http://www.ingenuity.com/) was applied for Bioinformatic analysis to analyze the canonical 
pathways, networks, and biological functions of miRNAs. IPA network diagrams were generated 
based on their score, which is calculated by taking the negative log of the P-value for the 
likelihood these molecules would be found together by chance alone. A higher score indicates 
greater statistical significance that molecules depicted in the network are interconnected. Each 
network includes several partner molecules that were assigned to the network by IPA, some of 
which are not among the input focus genes. The latest version (17199142, Release Date: 17 
September, 2013) was used. 
 
 
 
 
 
 
 
 
 
  
 
 
 
15 
 
 
 
 
CHAPTER III 
RESULTS 
 
Cell Cycle Analysis 
We expect to observe statistically significant genetic-association between SNPs' in the DNA 
repair pathway and the quantity of cells arrested in S-phase based on the ability of the SNPs to 
modulate DNA repair, when cell lines are treated with chemotherapeutic agents. Addition of 
vitamin D as when compared to the cell lines treated only with the drugs may show the effect of 
vitamin D in DNA repair which may in turn be related to the SNP based polymorphism of the 
vitamin D pathway genes of the corresponding cell lines. 
 
Initial results have supported our expectations that chemotherapeutic agents would lead to an 
accumulation of cells in the S-phase and that differential clustering occurs based on treatment 
and genome. A large difference in the Fst value of genes in Caucasian American and African 
cells lines was found. This allelic difference could be influencing DNA repair efficiency and 
therefore the number of cells in the S-phase.  
 
Coding and Non-coding DNA Repair Transcriptome 
To identify specific gene expression and gene networks associated with the 6 common DNA 
repair pathways and their targeted top 22 miRNA’s. We will perform Quantitative real-time 
PCR. We expect to observe gene expression patterns and thus DNA repair transcriptomic-
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networks to differ between African and Caucasian population derived cell lines thus suggesting 
DNA repair as one significant cause of differences between presentation of tumor biology and 
cancer outcomes between African and Caucasian patients. 
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CHAPTER IV 
DISCUSSION 
 
Recent studies have found a difference in cancer severity between Caucasian Americans and 
African Americans. While this difference can be explained in part by socioeconomic conditions, 
 here we focus on the second component, the biological basis of the difference.  The 1000-
genome project (http://www.1000genomes.org/) database provides a tool to identify SNPs in the 
DNA repair pathways that may contribute to biological differences in cancer presentation and 
outcome between the two ethnic groups. Several DNA repair genes showed a fixation 
index (FST) value greater than 75%. FST is a measure of population differentiation due to genetic 
structural differences based on allele frequencies. This difference in the Fst values of African and 
Caucasian American cells suggests that genetic differences in DNA repair genes exist, which 
may in turn contribute to  underlying differences in DNA repair capacity.   These genes with 
high Fst value represent all six known common DNA repair pathways and DDR response. This 
supports our hypothesis that genetic variations exist in the DNA repair genes and that certain 
alleles may provide advantages in repair capacity.  Our results are in agreement with several 
recent reports suggesting a causal link between genes from DNA repair and cancer 
presentation14-16. 
 
In our study, HMGB1 and TP53 are important genes with high Fst values. HMGB1 enhances 
transcription and has recently been found to be a cytokine that plays a role in immunological 
  
 
 
 
18 
 
 
 
 
responses17. Previous research has suggested that high levels of HMGB1 expression may support 
cancer cell proliferation. When HMGB1 expression was down-regulated, prostate cancer cells 
underwent apoptosis decreasing cancer cell number and growth18. Because there is a large 
variation in the gene between the two populations, the level of HMGB1 may be an important 
gene influencing the disparity in cancer symptoms. TP53, also known as “tumor protein 53,” is a 
well-known tumor suppressor that acts as a checkpoint regulating cell replication. It binds DNA 
strands and determines if there is any DNA damage. If damage exists, it activates repair 
pathways or apoptosis. A mutation, or SNP, in this gene could interfere with its ability to inhibit 
accumulation of DNA damage, restrict unchecked replication of cells, and disrupt tumor 
formation. The high percentage differences in the SNPs of this gene may also lead to variations 
in functional efficiency.  
 
By examining the genomic basis of biological variation, one of the aspects of racial and ethnic 
disparities in disease patterns, research such as this may shed light on the etiology of many 
complex diseases and identify new approaches to prevent these diseases in high risk populations. 
Results obtained from the cell cycle analysis showed increased S-phase arrest in cells treated 
with chemotherapeutic agents than cells in control groups. This is expected because the 
chemotherapeutic agents damage the DNA preventing it from passing the replication checkpoints 
in the S-phase.  Genetic association studies of S phase arrest with SNPs in DNA repair pathways 
will shed light on the influence of specific SNPs on S phase progression and underlying DNA 
repair capacity.  This work is currently in progress. 
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Based on the data we have obtained thus far, we intend to expand our research focus to 
discovering specific DNA repair pathway signaling networks that differ between the two 
populations. By applying the knowledge of the clinical (phenotypic) differences in presentation 
and outcome between these populations to molecular underpinnings behind them (genotype), we 
plan to identify factors that can be exploited to eliminate cancer disparities. This study will not 
only prove beneficial in the cancer survival outcomes in African Americans and Caucasians, but 
will be a pivotal breakthrough in our quest towards personalized medicine. 
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